Journal:
:international journal of hematology-oncology and stem cell research
0
ardeshir ghavamzadeh professor of medicine, hematology, oncology and stem cell transplantation research center, tehran university of medical sciences, tehran, iran.
mehrzad mirzania hematologist and medical oncologist, cancer research center, cancer institute, tehran university of medical sciences, tehran, iran.
naser kamalian professor of medicine, tehran university of medical sciences, tehran, iran.
nahid sedighi associate professor of medicine, advanced diagnostic and interventional radiology, msk research group, tehran university of medical sciences, tehran, iran.
parisima azimi tehran university of medical sciences, tehran, iran.
currently, hematopoietic stem cell transplantation (hsct) is the only curative option for patients with beta-thalassemia major, but liver iron overload in these patients will not decrease and hepatic fibrosis may still progress despite successful hsct. liver biopsy samples were taken from 14 patients (out of 25 patients) who underwent hsct. all patients met three criteria: negative hcv antibody...
